<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34903448</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0828</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European journal of internal medicine</Title><ISOAbbreviation>Eur J Intern Med</ISOAbbreviation></Journal><ArticleTitle>Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>41</EndPage><MedlinePgn>36-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejim.2021.11.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0953-6205(21)00405-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge.</AbstractText><AbstractText Label="METHODS">Longitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients &gt;18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of &#x2265;3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion.</AbstractText><AbstractText Label="RESULTS">At 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones.</AbstractText><AbstractText Label="CONCLUSIONS">Burden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may benefit from specific follow up strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy. Electronic address: 00.carlo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zocchi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassetti</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverii</LastName><ForeName>Maria Vittoria</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giovannoni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verrillo</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoloni</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavorini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungar</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivotto</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasero</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fattirolli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchionni</LastName><ForeName>Niccol&#xf3;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AOU Careggi COVID-19 Follow-up study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Intern Med</MedlineTA><NlmUniqueID>9003220</NlmUniqueID><ISSNLinking>0953-6205</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Gender medicine</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>None to disclose for the present work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34903448</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pii">S0953-6205(21)00405-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) emergency dashboard. https://covid19.who.int. Published, 2021.</Citation></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020:1&#x2013;13. doi: 10.1056/nejmoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369 doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C.M., Jones S.A., Yang J., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369 doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372 doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA - J Am Med Assoc. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. Journals Gerontol - Ser A Biol Sci Med Sci. 2001;56(3) doi: 10.1093/gerona/56.3.m146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.m146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C., Rozzini R., Vannini M., et al. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study. BMJ Open. 2020;10(9) doi: 10.1136/bmjopen-2020-040729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040729</ArticleId><ArticleId IdType="pmc">PMC7520809</ArticleId><ArticleId IdType="pubmed">32978207</ArticleId></ArticleIdList></Reference><Reference><Citation>Papachristou E., Wannamethee S.G., Lennon L.T., et al. Ability of Self-Reported Frailty Components to Predict Incident Disability, Falls, and All-Cause Mortality: results From a Population-Based Study of Older British Men. J Am Med Dir Assoc. 2017;18(2):152&#x2013;157. doi: 10.1016/j.jamda.2016.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.08.020</ArticleId><ArticleId IdType="pmc">PMC5270459</ArticleId><ArticleId IdType="pubmed">27742583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi: 10.7326/m20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Falagas M.E., Mourtzoukou E.G., Vardakas K.Z. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845&#x2013;1863. doi: 10.1016/J.RMED.2007.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RMED.2007.04.011</ArticleId><ArticleId IdType="pubmed">17544265</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H., de Gruijter N.M., Raine C., et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020 111. 2020;11(1):1&#x2013;10. doi: 10.1038/s41467-020-19741-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X., Hu X., Ekumi I.O., et al. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. Am J Geriatr Psychiatry. 2020;28(10):1030&#x2013;1039. doi: 10.1016/j.jagp.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli F.V., Milne S., Cheung C., et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33 doi: 10.1016/j.eclinm.2021.100789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100789</ArticleId><ArticleId IdType="pmc">PMC7971471</ArticleId><ArticleId IdType="pubmed">33758801</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung J.M., Niikura M., CWT Yang, Sin D.D. COVID-19 and COPD. Eur Respir J. 2020;56(2) doi: 10.1183/13993003.02108-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02108-2020</ArticleId><ArticleId IdType="pmc">PMC7424116</ArticleId><ArticleId IdType="pubmed">32817205</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried L.P., Tangen C.M., Walston J., et al. Frailty in Older Adults: evidence for a Phenotype. J. Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M146&#x2013;M157. doi: 10.1093/gerona/56.3.m146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.m146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt J., Carter B., Vilches-Moraga A., et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Heal. 2020;5(8):e444&#x2013;e451. doi: 10.1016/S2468-2667(20)30146-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30146-8</ArticleId><ArticleId IdType="pmc">PMC7326416</ArticleId><ArticleId IdType="pubmed">32619408</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C., Ungar A., Rozzini R., et al. Predicting Mortality Risk in Older Hospitalized Persons with COVID-19: a comparison of the COVID-19 Mortality Risk Score with Frailty and Disability. Journal of the American Medical Directors Association. 2021 doi: 10.1016/j.jamda.2021.05.028. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.05.028</ArticleId><ArticleId IdType="pmc">PMC8249822</ArticleId><ArticleId IdType="pubmed">34334160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sablerolles R.S.G., Lafeber M., van Kempen J.A.L., et al. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study. Lancet Heal Longev. 2021;2(3):e163&#x2013;e170. doi: 10.1016/s2666-7568(21)00006-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-7568(21)00006-4</ArticleId><ArticleId IdType="pmc">PMC7906710</ArticleId><ArticleId IdType="pubmed">33655235</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G., Newcomb R., Cowl C.T., et al. Post&#x2013;COVID-19 Syndrome (Long Haul Syndrome): description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clin Proc. 2021;96(7):1782&#x2013;1791. doi: 10.1016/J.MAYOCP.2021.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MAYOCP.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>